Abla A. Creasey
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 4
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 11
- Immunology top 2%
- Immune Response and Inflammation 5
- interferon and immune responses 4
- Epidemiology top 5%
- Sepsis Diagnosis and Treatment 11
-
- Cytokine Signaling Pathways and Interactions 5
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Antimicrobial Peptides and Activities 3
- Co-authors
- R. YamamotoLeo S. LinAlvin ChangFletcher B. TaylorLarry P. FeigenTC WunL. B. HinshawMartha Ladner
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Molecular and Cellular Biology (3 papers)Critical Care Medicine (3 papers)
- Partner nations
- United StatesNetherlandsJapan
In The Last Decade
Abla A. Creasey
42 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Internal Medicine 410
- Hematology 999
- Immunology 1.0k
- Critical Care and Intensive Care Medicine 199
- Epidemiology 766
Countries citing papers authored by Abla A. Creasey
This map shows the geographic impact of Abla A. Creasey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abla A. Creasey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abla A. Creasey more than expected).
Fields of papers citing papers by Abla A. Creasey
This network shows the impact of papers produced by Abla A. Creasey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abla A. Creasey. The network helps show where Abla A. Creasey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abla A. Creasey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | 2019 | 10 | |
| 3 | 2018 | 5 | |
| 4 | 2012 | 36 | |
| 5 | 2009 | 35 | |
| 6 | 2007 | 53 | |
| 7 | 2001 | 193 | |
| 8 | 2001 | 20 | |
| 9 | 2001 | 55 | |
| 10 | 2001 | 36 | |
| 11 | 1999 | 26 | |
| 12 | 1998 | 69 | |
| 13 | 1998 | 37 | |
| 14 | 1998 | 176 | |
| 15 | 1996 | 98 | |
| 16 | 1993 | 446 | |
| 17 | 1990 | 5 | |
| 18 | 1987 | 13 | |
| 19 | 1987 | 14 | |
| 20 | 1983 | 13 |
About Abla A. Creasey
Abla A. Creasey is a scholar working on Hematology, Internal Medicine, Immunology, Critical Care and Intensive Care Medicine and Microbiology, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Sepsis Diagnosis and Treatment (11 papers), Immune Response and Inflammation (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), interferon and immune responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Internal Medicine (410 citations), Hematology (999 citations), Immunology (1.0k citations), Critical Care and Intensive Care Medicine (199 citations) and Epidemiology (766 citations). Abla A. Creasey has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include R. Yamamoto, Leo S. Lin, Alvin Chang, Fletcher B. Taylor, Larry P. Feigen, TC Wun, L. B. Hinshaw, Martha Ladner, Alice M. Wang and James E. Strickler. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, Critical Care Medicine, Blood and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.